ZA200709499B - Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(S)-carbonitrile formulation - Google Patents
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(S)-carbonitrile formulationInfo
- Publication number
- ZA200709499B ZA200709499B ZA200709499A ZA200709499A ZA200709499B ZA 200709499 B ZA200709499 B ZA 200709499B ZA 200709499 A ZA200709499 A ZA 200709499A ZA 200709499 A ZA200709499 A ZA 200709499A ZA 200709499 B ZA200709499 B ZA 200709499B
- Authority
- ZA
- South Africa
- Prior art keywords
- adamant
- ylamino
- pyrrolidine
- acetyl
- hydroxy
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68971905P | 2005-06-10 | 2005-06-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200709499B true ZA200709499B (en) | 2008-11-26 |
Family
ID=39567780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200709499A ZA200709499B (en) | 2005-06-10 | 2007-11-05 | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(S)-carbonitrile formulation |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101208085B (en) |
ZA (1) | ZA200709499B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110135411A (en) * | 2009-03-27 | 2011-12-16 | 브리스톨-마이어스 스큅 컴퍼니 | Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors |
CA2777231A1 (en) * | 2009-10-23 | 2011-04-28 | Merck Sharp & Dohme Corp. | Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone |
CN103040759A (en) * | 2012-11-20 | 2013-04-17 | 北京阜康仁生物制药科技有限公司 | Sustained-release oral solid preparation by using vildagliptin as active component |
CN103845326B (en) * | 2014-03-24 | 2017-07-07 | 江苏奥赛康药业股份有限公司 | Compound of vildagliptin and melbine and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1537880A4 (en) * | 2002-09-11 | 2009-07-01 | Takeda Pharmaceutical | Sustained release preparation |
US8980322B2 (en) * | 2003-03-17 | 2015-03-17 | Takeda Pharmaceutical Company Limited | Controlled release composition |
-
2006
- 2006-06-08 CN CN2006800205753A patent/CN101208085B/en active Active
-
2007
- 2007-11-05 ZA ZA200709499A patent/ZA200709499B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101208085B (en) | 2011-01-05 |
CN101208085A (en) | 2008-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1117037A1 (en) | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)- carbonitrile formulation | |
IL187657A0 (en) | Substituted arylpyrazoles for use against parasitites | |
ZA200707250B (en) | Extended release formulation of levetiracetam | |
EP1731882A4 (en) | Structure for reducing agent container | |
IL191287A0 (en) | Atorvastatin formulation | |
ZA200802602B (en) | Controlled release formulation | |
GB0526419D0 (en) | Formulation | |
ZA200705027B (en) | Phenyl-piperazin methanone derivatives | |
GB0517673D0 (en) | Formulation | |
GB0516481D0 (en) | Trailers | |
IL184847A0 (en) | Pharmaceutical composition comprising an indolylmaleimide derivative | |
GB0423565D0 (en) | Formulation | |
GB0624565D0 (en) | Veterinary composition | |
GB0412530D0 (en) | Formulation | |
GB0518129D0 (en) | Ramipril formulation | |
ZA200709499B (en) | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(S)-carbonitrile formulation | |
GB0508991D0 (en) | Veterinary composition | |
GB0501030D0 (en) | Formulation | |
PL1928232T3 (en) | Solid formulation | |
GB0426661D0 (en) | Pyrrolidine compounds | |
SG123660A1 (en) | Spanner | |
HU0400305D0 (en) | Set for spine-fixture | |
AU305535S (en) | Tool rack set | |
ZA200703442B (en) | Proline derivatives | |
GB0414083D0 (en) | Horsebox loading bar |